500 mg
Context: Randomized placebo-controlled crossover study in women with chronic urinary tract infection and healthy controls
Formulation: Oral-mucosal formulations are not dose-equivalent to injectable or topical formulations.
Route safety: Study exposure, not a general supplementation recommendation. Plasma homocysteine increased during supplementation.